Welcome to our dedicated page for Vicor SEC filings (Ticker: VICR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking design-win announcements and patent updates in Vicor’s SEC reports can feel like tracing voltage through a multilayer PCB. Each Vicor annual report 10-K spans intricate discussions of FPA™ architectures, customer concentration in hyperscale computing, and defense backlog—details critical yet time-consuming to extract.
Stock Titan solves that bottleneck. Our AI-powered summaries turn a 300-page document into a concise brief, so understanding Vicor SEC documents with AI becomes routine. Need the latest Vicor quarterly earnings report 10-Q filing? We ingest it in real time from EDGAR, highlight segment revenue trends, and compare R&D outlays quarter-over-quarter. Monitoring ownership shifts? Receive instant alerts for every Vicor Form 4 insider transactions real-time, complete with context on executive stock transactions and historical patterns.
Investors often ask, “Which new platforms adopted Vicor’s modular converters?” or “Did defense bookings grow this quarter?” The answers hide in multiple forms:
- 10-K and 10-Q: efficiency metrics, licensing revenue, and supply-chain risks—now Vicor SEC filings explained simply.
- 8-K: product qualification wins—Vicor 8-K material events explained in plain language.
- DEF 14A proxy: Vicor proxy statement executive compensation trends and governance insights.
- Form 4: Vicor insider trading Form 4 transactions summarized alongside peer activity.
Whether you’re conducting a Vicor earnings report filing analysis before a model update or verifying a Vicor executive stock transactions Form 4 prior to a trade, our expert commentary and AI highlights surface the nuggets that move the power-electronics market. All filings, all formats, delivered the moment they post—so you act before the circuit closes.
Vicor Corp (VICR) – SEC Form 4 filing dated 07/10/2025
Philip D. Davies, the company’s Vice President of Global Sales & Marketing and a Director, reported a grant of 20,000 non-qualified stock options on 07/09/2025. The options carry an exercise price of $46.72, expire on 07/09/2035, and vest over a five-year period under Vicor’s Amended & Restated 2000 Stock Option and Incentive Plan. No common shares were bought or sold in the open market.
After this award, Davies’ direct holdings stand at 15,763 shares of common stock and 20,000 derivative securities (options). The filing reflects routine executive compensation and does not disclose any other material transactions.
Vicor Corporation (NASDAQ: VICR) filed a Form 8-K reporting the voting results of its 20 June 2025 Annual Meeting (Item 5.07).
Shareholders considered one proposal: set the Board size at 11 and elect the entire slate of 11 directors to serve until the 2026 meeting. Support was strong; each nominee received between 127.2 million and 131.9 million votes FOR, while withheld votes ranged from 3.97 million to 8.69 million. No broker non-votes or abstentions were recorded.
Vicor’s dual-class structure remains in place—each Common share equals one vote, each Class B share equals ten votes—reinforcing the existing voting power dynamics.
The filing contains no financial metrics, transactions, or other material events beyond routine governance matters.
Vicor Corp (VICR) – Form 4 insider filing dated 06/23/2025
Director John Zheng Shen received a grant of 4,539 non-qualified stock options on 06/20/2025 under the company’s Amended & Restated 2000 Stock Option and Incentive Plan. The options carry an exercise price of $44.07 per share and expire on 06/20/2035. No shares were bought or sold in the open market; the transaction strictly reflects a compensation-related award. Following the grant, Shen beneficially owns 4,539 derivative securities linked to common stock, held directly.
The filing is routine and does not disclose any immediate cash transactions, changes in ownership percentage, or broader strategic implications for Vicor’s capital structure.
Vicor Corp (VICR) – Form 4 insider filing dated 06/23/2025 discloses that Claudio Tuozzolo, a Corporate Vice President and Director, received a grant of 4,539 non-qualified stock options on 06/20/2025 under the company’s Amended & Restated 2000 Stock Option and Incentive Plan. The options have an exercise price of $44.07, a 10-year term expiring 06/20/2035, and will vest over five years (standard 20 % per-year schedule implied by plan language). No cash consideration was paid for the grant (price $0).
No shares of common stock were acquired or disposed of in Table I; Tuozzolo’s direct beneficial ownership remains 33,622 shares following the transaction. After the option grant, he also directly holds 4,539 derivative securities. The filing includes the customary signature by attorney-in-fact on 06/23/2025 and contains no indications of a Rule 10b5-1 trading plan or any sales activity.
From an investor perspective, the filing represents routine equity-based compensation aimed at aligning executive incentives with shareholder interests. It does not alter Vicor’s capital structure, cash flow, or immediate financial outlook. The relatively modest size of the option grant (≈0.01 % of the 43 million shares outstanding) suggests minimal dilution risk and limited market impact.
Vicor Corporation (VICR) – Form 4 insider transaction summary
On 06/20/2025, director Andrew D’Amico received a non-qualified stock option for 4,539 common shares of Vicor. The option’s exercise price is $44.07—generally the market price at the grant date—and it will expire on 06/20/2035. According to the footnote, the grant was made under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and will vest ratably over five years. No shares were purchased or sold outright; the filing only records the derivative security grant. Following the transaction, D’Amico beneficially owns 4,539 derivative securities (options) and no change to any direct common-stock position is disclosed.
This type of grant is a routine component of director compensation. It modestly aligns the director’s interests with shareholders by linking potential value to future share-price performance, but the size of the grant—4,539 shares, roughly US$0.2 million based on the strike price—is small relative to Vicor’s market capitalization and average daily trading volume. There are no cash proceeds to Vicor and no immediate dilution because the options are unexercised. Investors should consider it an ordinary governance event rather than a signal of near-term fundamental change.
Vicor Corp (VICR) – Form 4 Insider Filing
Director Estia J. Eichten reported the grant of 4,539 non-qualified stock options on 20 June 2025 at an exercise price of $44.07 per share, expiring 20 June 2035. The award was issued under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and will vest over five years, reinforcing long-term alignment with shareholders. No open-market purchases or sales of common stock were disclosed in Table I; the director continues to hold 230,267 shares of Vicor common stock directly after the reported transaction.
The filing indicates routine equity-based compensation for a board member and does not materially alter the company’s share count or insider ownership structure. Because the transaction is an acquisition of derivative securities rather than a disposition, it does not signal near-term liquidity by the insider. Overall, the Form 4 suggests continued commitment by the director but carries limited financial impact for investors given the modest size of the award relative to Vicor’s outstanding shares and daily trading volume.
On June 20, 2025, Vicor Corp (VICR) filed a Form 4 detailing an equity award to its Chief Financial Officer, Treasurer, Secretary and Director, James F. Schmidt.
The filing shows a grant of 4,539 non-qualified stock options with an exercise price of $44.07 per share under the company’s Amended and Restated 2000 Stock Option and Incentive Plan. The options vest over five years and expire on June 20, 2035. After the grant, Mr. Schmidt directly holds 4,539 options and 875 shares of common stock.
No purchases or sales of common shares were reported. Given the award’s small size relative to Vicor’s total shares outstanding, the disclosure is routine and implies minimal dilution.